Wutah dodolan YoY sajrone rolas wulan kepungkur: Synlogic, Inc. (SYBX)

Logo grafis Synlogic (SYBX)

The relative sales growth over a 12-month period compared to last year, as shown on this GURU.Markets chart, confirms the stability of non-cyclical biopharmaceuticals with steady demand for Synlogic, Inc. (SYBX). The -99.80 level captures recent values for intellectual property monetization and M&A transactions. Business reliability is bolstered by strictly controlled cold chain supplies of synthetic biotics, eliminating any logistical disruptions.

Wutah dodolan YoY sajrone rolas wulan kepungkur: synlogictx.com (SYBX) kanggo 11.02.2024 - 24.01.2026

Ringkesan rincian data analitis synlogictx.com (SYBX)

- nilai pasar lan prakiraan target analis:
- indikator kapitalisasi bursa perusahaan:
Pambiji fundamental perusahaan:Synlogic, Inc.
Produk seri Synlogic, Inc.

Year-over-year (TTM) sales growth reflects actual revenue dynamics, neutralizing quarterly distortions through a rolling twelve-month calculation. Analyzing the TTM year-over-year sales growth rate chart allows for a real-time assessment of turnover velocity. This indicator captures the pace of business expansion or contraction, determining the sustainability of cash flows. For Synlogic, Inc. (SYBX), this metric is critical as it demonstrates stagnation due to the winding down of core developments. Amidst the liquidation of the pipeline, the decline in this metric confirms the minimal operational value of the assets.

Pesaing Synlogic, Inc. (SYBX)

Ascendis (ASND) - Wutah pendapatan taun lumaku|MDGL - Wutah dodolan YoY sajrone rolas wulan kepungkur|CORT: Wutah dodolan YoY sajrone rolas wulan kepungkur|RYTM: Wutah dodolan YoY (TTM)|AKRO - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur Metsera Therapeutics|MoonLake Corp (MLTX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY sajrone rolas wulan kepungkur crinetics.com (CRNX)|Wutah pendapatan YoY sajrone 12 wulan kepungkur newamsterdampharma.com NAMS|Wutah dodolan YoY sajrone rolas wulan kepungkur Soleno Therapeutics Inc SLNO|Wutah dodolan YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Wutah dodolan YoY (TTM)|Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Wutah dodolan YoY sajrone rolas wulan kepungkur|Wutah pendapatan YoY sajrone 12 wulan kepungkur MiMedx Group, Inc.|Wutah dodolan YoY sajrone rolas wulan kepungkur Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Wutah pendapatan taunan sajrone rolas wulan kepungkur|Wutah dodolan YoY (TTM) MBX|Wutah pendapatan YoY sajrone 12 wulan kepungkur Altimmune, Inc. ALT|Wutah dodolan YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Wutah pendapatan taun lumaku|BIOA: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Dinamika pendapatan YoY sajrone rolas wulan kepungkur BMEA (Biomea Fusion)|QNCX (quincetx.com) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Fractyl - Dinamika pendapatan YoY sajrone rolas wulan kepungkur|VTVT (vTv Therapeutics Inc) - Wutah dodolan YoY (TTM)|Agape ATP - Wutah dodolan taun lumaku|Wutah pendapatan YoY sajrone 12 wulan kepungkur PLUR (Pluri Inc)|Wutah pendapatan taunan sajrone rolas wulan kepungkur Lipocine Inc|Wutah dodolan YoY sajrone rolas wulan kepungkur Matinas BioPharma Holdings MTNB|Wutah pendapatan taunan sajrone rolas wulan kepungkur Spruce Biosciences (SPRB)|GLTO: Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan taun lumaku CTCX|LUMO (Lumos Pharma) - Wutah pendapatan YoY sajrone 12 wulan kepungkur|Wutah dodolan YoY sajrone 12 wulan kepungkur ONVO|RDUS (Radius Pharmaceuticals) - Wutah dodolan YoY (TTM)